PAK4-targeting PROTAC inhibits bladder cancer cell proliferation

Shan Xu, Hongjun Xie, Zhao Yang, Zhenkun Ma, Xiaojing Bai, Xiaoyu Feng, Jiale An, Bohan Ma · 2026

Read PAK4-targeting PROTAC inhibits bladder cancer cell proliferation by Shan Xu, Hongjun Xie, Zhao Yang, Zhenkun Ma, Xiaojing Bai, Xiaoyu Feng, Jiale An, Bohan Ma (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0358561.txt.

Description

Shan Xu leads a team of eight testing a protein destroying drug against bladder cancer in PLOS ONE in 2026. The drug, a peptide based chimera the group developed earlier, does not merely block its target, a growth promoting kinase called PAK4; it tags the protein for disposal by the cell. First the team confirmed the kinase runs high in bladder tumor tissue, then compared cancer cells genetically stripped of it with cells treated by the drug, in dishes and in animals.

Both routes told the same story. Without the kinase, a key growth pathway went quiet, cells stalled before copying their DNA, and a self destruct program switched on. Tumors grew significantly more slowly in mice under both the knockout and the drug. Because a degrader removes the whole protein rather than one activity, the authors argue it may outflank resistance that defeats ordinary kinase blockers.

Catalog record

CREATORShan Xu, Hongjun Xie, Zhao Yang, Zhenkun Ma, Xiaojing Bai, Xiaoyu Feng, Jiale An, Bohan Ma
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE44550
LICENSECC_BY
RIGHTSCC BY
SOURCEPLOS

Source: https://doi.org/10.1371/journal.pone.0358561

Browse the full library · About the Tower of Babel